Subscribe To
Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy Program
Call scheduled for Monday, December 5, 2022 at 8:00 a.m. ET SOUTH SAN FRANCISCO, Calif., Dec. 02, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies to treat cancer, today announced that it will host a conference call on Monday, December 5, 2022 at 8:00 a.m. […] The post Nkarta to Host Conference Call to Discuss Updated Clinical Data from NKX019 NK Cell Therapy Program appeared first on ForexTV...
Read More
Posted: Dec 2 2022, 21:02
Author Name: forextv
Views: 102539